BRCA1 and neoplasm: Pathogenic BRCA1/2 mutations confer an increased risk of developing neoplasms, especially of the breasts and ovaries: in our series, three patients with these PVs showed a typical phenotype, highly consistent with the syndrome (including the patient with double mutation).